HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

megakaryocyte potentiating factor

controls rate & extent of cytoplasmic maturation during megakaryocyte development; RefSeq NM_018857 (mouse); NM_013404 (human); do not confuse with SMRP protein, human
Also Known As:
CAK1 antigen, human; ERC protein, rat; MPF protein, mouse; MSLN protein, human; Megakaryocyte potentiating factor, human; Msln protein, mouse; Msln protein, rat; glycoprotein CAK1, human; megakaryocyte potentiating factor, mouse; mesothelin; mesothelin protein, human; mesothelin protein, mouse; mesothelin protein, rat
Networked: 431 relevant articles (15 outcomes, 103 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Pastan, Ira: 54 articles (12/2015 - 06/2002)
2. Hassan, Raffit: 45 articles (12/2015 - 11/2002)
3. Hino, Okio: 26 articles (10/2014 - 09/2006)
4. Creaney, Jenette: 23 articles (07/2015 - 11/2003)
5. Ho, Mitchell: 23 articles (01/2015 - 05/2005)
6. Robinson, Bruce W S: 17 articles (10/2014 - 11/2003)
7. Maeda, Masahiro: 16 articles (10/2014 - 09/2006)
8. Hagiwara, Yoshiaki: 15 articles (01/2014 - 09/2006)
9. Zhang, Jingli: 13 articles (12/2015 - 05/2005)
10. Scholler, Nathalie: 12 articles (07/2015 - 03/2007)

Related Diseases

1. Neoplasms (Cancer)
2. Mesothelioma
3. Ovarian Neoplasms (Ovarian Cancer)
4. Pancreatic Neoplasms (Pancreatic Cancer)
5. Adenocarcinoma

Related Drugs and Biologics

1. Immunotoxins (Immunotoxin)
2. Antigens
3. Biological Markers (Surrogate Marker)
4. Small Interfering RNA (siRNA)
5. Monoclonal Antibodies
6. DNA Vaccines
7. Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
8. gemcitabine
9. megakaryocyte potentiating factor
10. Asbestos

Related Therapies and Procedures

1. Immunotherapy
2. Heterologous Transplantation (Xenotransplantation)
3. Drug Therapy (Chemotherapy)
4. Quantum Dots (Quantum Dot)
5. Intravenous Infusions